![Michael Brooks](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 2 M $ al 31/05/2026
Michael Brooks is currently President at Edesa Biotech, Inc. since 2019, with employment at the company starting in 2015.
Former positions include Director-Business Development at Cipher Pharmaceuticals, Inc. from 2010 to 2015, President at Edesa Biotech, Inc. (Old), and Vice President-Corporate Development & Strategy at Edesa Biotech Research, Inc. Education includes an MBA from Rotman School of Management and undergraduate and doctorate degrees from the University of Toronto.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
EDESA BIOTECH, INC. 3,28 % | 27/05/2026 | 291.479 ( 3,28 % ) | 2 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| EDESA BIOTECH, INC. | Presidente | 07/06/2019 |
| Empresas | Cargo | Fin |
|---|---|---|
| CIPHER PHARMACEUTICALS INC. | Corporate Officer/Principal | 01/01/2015 |
Edesa Biotech Research, Inc. | Corporate Officer/Principal | - |
Edesa Biotech, Inc. (Old)
 Edesa Biotech, Inc. (Old) Pharmaceuticals: MajorHealth Technology Develops novel non-steroidal molecules for the treatment of allergic contact dermatitis | Presidente | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 6 |
|---|---|
Cipher Pharmaceuticals, Inc.
 Cipher Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Provides laboratory testing and medical imaging services | Health Technology |
Rotman School of Management
 Rotman School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Edesa Biotech, Inc. (Old)
Edesa Biotech, Inc. (Old) Pharmaceuticals: MajorHealth Technology Develops novel non-steroidal molecules for the treatment of allergic contact dermatitis | Health Technology |
Edesa Biotech, Inc.
 Edesa Biotech, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for treatment of chronic allergic contact dermatitis | Health Technology |
Edesa Biotech Research, Inc. |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
